Epigallocatechin-3-gallate modulates antioxidant and DNA repair-related proteins in exocrine glands of a primary Sjogren's syndrome mouse model prior to disease onset

References

• Bolstad AI, Jonsson R. Genetic aspects of Sjögren's syndrome. Arthritis Res.. 2002; 4:353–359.
   PubMedGoogle Scholar
• Yamamoto K. Pathogenesis of Sjögren's syndrome. Autoimmun. Rev.. 2003; 2:13–18.
   PubMed Web of Science ®Google Scholar
• Sawalha AH, Potts R, Schmid WR, Scofield RH, Harley JB. The genetics of primary Sjögren's syndrome. Curr. Rheumatol. Rep.. 2003; 5:324–332.
   PubMedGoogle Scholar
• Rehman HU. Sjögren's syndrome. Yonsei Med. J.. 2003; 44:947–954.
   PubMedGoogle Scholar
• Mahoney EJ, Spiegel JH. Sjögren's disease. Otolaryngol. Clin. N. Amer.. 2003; 36:733–745.
   PubMedGoogle Scholar
• Venables PJ. Sjögren's syndrome. Best Pract. Res. Clin. Rheumatol.. 2004; 18:313–329.
   PubMedGoogle Scholar
• Manganelli P, Fietta P. Apoptosis and Sjögren's syndrome. Semin. Arthritis Rheum.. 2003; 33:49–65.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Arakaki R, Ishimaru N. The role of caspase cascade on the development of primary Sjögren's syndrome. J. Med. Invest.. 2003; 50:32–38.
   PubMedGoogle Scholar
• Hayashi Y, Arakaki R, Ishimaru N. Apoptosis and estrogen deficiency in primary Sjögren's syndrome. Curr. Opin. Rheumatol.. 2004; 16:522–526.
   PubMed Web of Science ®Google Scholar
• Burbelo PD, Leahy HP, Issa AT, Groot S, Baraniuk JN, Nikolov NP, Illei GG, Iadarola MJ. Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome. Autoimmunity. 2009; 42:515–524.
   PubMed Web of Science ®Google Scholar
• Cravens PD, Lipsky PE. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol. Cell. Biol.. 2002; 80:497–505.
   PubMed Web of Science ®Google Scholar
• van Woerkom JM, Geertzema JG, Nikkels PG, Kruize AA, Smeenk RJ, Vroom TM. Expression of Ro/SS-A and La/SS-B determined by immunohistochemistry in healthy, inflamed and autoimmune diseased human tissues: a generalized phenomenon. Clin. Exp. Rheumatol.. 2004; 22:285–292.
   PubMedGoogle Scholar
• Thompson C, Pomeranz Krummel DA, Jacobsen H, Nagai K, Cooke A. Identification of nuclear spliceosomal antigens targeted by NOD mouse antibodies following sodium iodide intake. Autoimmunity. 2006; 39:99–106.
   PubMed Web of Science ®Google Scholar
• Gillespie K, Kodani I, Dickinson DP, Ogbureke KUE, Camba AM, Wu M, Looney S, Chu TC, Qin H, Bisch F, Sharawy M, Schuster GS, Hsu SD. Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. Life Sci.. 2008; 83:581–588.
   PubMed Web of Science ®Google Scholar
• Mukhtar H, Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr.. 2000; 71 6 Suppl: 1698S–1702S discussion 1703S–1704S.
   PubMed Web of Science ®Google Scholar
• Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol.. 2002; 42:25–54.
   PubMed Web of Science ®Google Scholar
• Katiyar SK, Elmets CA. Green tea polyphenolic antioxidants and skin photoprotection (Review). Int. J. Oncol.. 2001; 18:1307–1313.
   PubMed Web of Science ®Google Scholar
• Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, Nakachi K, Fujiki H. A new function of green tea: Prevention of lifestyle-related diseases. Ann. N.Y. Acad. Sci.. 2001; 928:274–280.
   PubMed Web of Science ®Google Scholar
• Green tea. Altern. Med. Rev.. 2000; 5:372–375.
   PubMedGoogle Scholar
• Hsu S, Dickinson D. Green Tea: A new approach to managing oral manifestations of Sjogren's Syndrome and skin manifestations of lupus. J. Biochem. Molec. Biol.. 2006; 39:229–239 Review.
   PubMedGoogle Scholar
• Hsu S, Dickinson DP, Qin H, Borke J, Ogbureke K, Winger JN, Walsh DS, Bollag WB, Stoppler H, Sharawy M, Schuster G. Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-alpha-induced cytotoxicity. Autoimmunity. 2007; 40:138–147.
   PubMed Web of Science ®Google Scholar
• Cha S, Peck AB, Humphreys-Beher MG. Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: An update. Crit. Rev. Oral Biol. Med.. 2002; 13:4–16.
   Google Scholar
• Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J. Nutr.. 2003; 133:3275S–3284S.
   PubMed Web of Science ®Google Scholar
• Yang CS, Lee MJ, Chen L. Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. Cancer Epidemiol. Biomarkers Prev.. 1999; 8:83–89.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Hsu S, Lewis J, Wataha J, Dickinson D, Singh B, Bollag WB, Lockwood P, Ueta E, Osaki TT, Schuster G. Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J. Pharmacol. Exp. Ther.. 2003; 307:230–236.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Staples J, Wataha J, Lewis J, Lockwood P, Schoenlein P, Rao S, Osaki T, Dickinson D, Kamatani T, Schuster G, Hsu S. Protective effects of EGCG on salivary gland cells treated with gamma-radiation or cis-platinum(II)diammine dichloride. Anticancer Res.. 2004; 24:3065–3073.
   PubMedGoogle Scholar
• Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J. Nutr.. 1998; 128:2334–2340.
   PubMed Web of Science ®Google Scholar
• Power JH, Asad S, Chataway TK, Chegini F, Manavis J, Temlett JA, Jensen PH, Blumbergs PC, Gai WP. Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology. Acta Neuropathol.. 2008; 115:611–622.
   PubMed Web of Science ®Google Scholar
• Kümin A, Schäfer M, Epp N, Bugnon P, Born-Berclaz C, Oxenius A, Klippel A, Bloch W, Werner S. Peroxiredoxin 6 is required for blood vessel integrity in wounded skin. J. Cell Biol.. 2007; 179:747–760.
   PubMed Web of Science ®Google Scholar
• Kümin A, Huber C, Rülicke T, Wolf E, Werner S. Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis. Am. J. Pathol.. 2006; 169:1194–1205.
   PubMed Web of Science ®Google Scholar
• Fatma N, Kubo E, Sen M, Agarwal N, Thoreson WB, Camras CB, Singh DP. Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca(2+) homeostasis. Brain Res.. 2008; 1233:63–78.
   PubMed Web of Science ®Google Scholar
• Wang Y, Feinstein SI, Fisher AB. Peroxiredoxin 6 as an antioxidant enzyme: protection of lung alveolar epithelial type II cells from H2O2-induced oxidative stress. J. Cell Biochem.. 2008; 104:1274–1285.
   PubMed Web of Science ®Google Scholar
• Kubo E, Fatma N, Akagi Y, Beier DR, Singh SP, Singh DP. TAT-mediated PRDX6 protein transduction protects against eye lens epithelial cell death and delays lens opacity. Am. J. Physiol. Cell Physiol.. 2008; 294:C842–C855.
   PubMed Web of Science ®Google Scholar
• Zhang G, Wang S. Proteomic approach to substrates related to MAPK pathway in 293T cells. Cell Biol. Int.. 2007; 31:1–10.
   PubMed Web of Science ®Google Scholar
• Daniels TE. Salivary histopathology in diagnosis of Sjogren's Syndrome. Scand. J. Rheumatol.. 1986; 61:36–43.
   Google Scholar
• Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology Sjogren's syndrome in labial salivary gland biopsies. Oral Surg.. 1974; 37:217–229.
   PubMedGoogle Scholar
• Lavasani S, Henriksson G, Brant M, Henriksson A, Radulic M, Manthorpe R, Bredberg A. Abnormal DNA damage-inducible protein in cells from Sjögren's syndrome patients. J. Autoimmun.. 1998; 11:363–369.
   PubMedGoogle Scholar
• Kurimoto C, Kawano S, Tsuji G, Hatachi S, Jikimoto T, Sugiyama D, Kasagi S, Komori T, Nakamura H, Yodoi J, Kumagai S. Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjögren's syndrome. J. Rheumatol.. 2007; 34:2035–2043.
   PubMed Web of Science ®Google Scholar
• Hübscher U, Maga G. DNA replication and repair bypass machines. Curr. Opin. Chem. Biol.. 2011; 15:627–635.
   Google Scholar
• Kirchmaier AL. Ub-family modifications at the replication fork: Regulating PCNA-interacting components. FEBS Lett.. 2011; 585:2920–2928.
   PubMedGoogle Scholar
• Celenligil-Nazliel H, Palali A Ahyan, Ruacan S. Analysis of in situ proliferative activity in oral gingival epithelium in patients with xerostomia. J. Periodont.. 2003; 74:247–254.
   PubMedGoogle Scholar
• Perl A. Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Curr. Opin. Rheumatol.. 2009; 21:443–447.
   PubMed Web of Science ®Google Scholar
• Kim SY, Chun E, Lee KY. Phospholipase A(2) of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis. Cell Death Differ.. 2011; 18:1573–1583.
   PubMedGoogle Scholar
• Eismann T, Huber N, Shin T, Kuboki S, Galloway E, Wyder M, Edwards MJ, Greis KD, Shertzer HG, Fisher AB, Lentsch AB. Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am J Physiol Gastrointest Liver Physiol. 2009; 296:G266–G274.
   PubMed Web of Science ®Google Scholar
• Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D, Oliveira-Emilio HC, Carpinelli AR, Curi R. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J. Physiol.. 2007; 583:9–24.
   PubMed Web of Science ®Google Scholar